Sentiment Trading

Novartis AG navigates turbulent market conditions, including US trade tensions and tariffs, while pursuing strategic acquisitions to bolster its portfolio and drive innovation.

Novartis AG has achieved a decade of consistent growth, with a 12% revenue increase in Q2 2025, driven by innovation and strategic leadership, positioning the company for future success in the pharmaceutical industry.